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Abstract
The ongoing cancer research has shown that malignant tumour cells have highly disrupted signalling transduction
pathways. In cancer cells, signalling pathways are altered to satisfy the demands of continuous proliferation and
survival. The changes in signalling pathways supporting uncontrolled cell growth, termed as rewiring, can lead to
dysregulation of cell fates e.g. apoptosis. Hence comparative analysis of normal and oncogenic signal transduction
pathways may provide insights into mechanisms of cancer drug-resistance and facilitate the discovery of novel and
effective anti-cancer therapies. Here we propose a hybrid modelling approach based on ordinary differential
equation (ODE) and machine learning to map network rewiring in the apoptotic pathways that may be responsible
for the increase of drug sensitivity of tumour cells in triple-negative breast cancer. Our method employs Genetic
Algorithm to search for the most likely network topologies by iteratively generating simulated protein
phosphorylation data using ODEs and the rewired network and then fitting the simulated data with real data of
cancer signalling and cell fate. Most of our predictions are consistent with experimental evidence from literature.
Combining the strengths of knowledge-driven and data-driven approaches, our hybrid model can help uncover
molecular mechanisms of cancer cell fate at systems level.
Introduction
The objective of anti-cancer therapeutics is to kill cancer
cells with minimum damage to the healthy cells. To this
end, a solid understanding of the cell fate decisions (e.g.
apoptosis, proliferation) of different cells under various
conditions would be required. It is well known that signal-
ling pathways play crucial roles in the regulation of cancer
cell fate [1]. However, it is challenging to understand the
dynamics of signal transduction at systems level, due to
non-linearity of the network dynamics, e.g. feedback and
crosstalk. In cancer cells, this becomes even more compli-
cated due to various types of alterations (e.g. DNA muta-
tions, genome rearrangement, epigenetic changes, and
pathway alterations). These alterations allow cancer cells to
adapt to new conditions and evolve drug resistance.
Therefore, to find effective anti-cancer therapies, cancer-
specific alterations in the signalling pathways must be
taken into account. Moreover, it is desirable to understand
how cancer cells respond to different combinations of
drugs, and how drug sensitivity can be enhanced. Genomic
and proteomic data of cellular responses to drugs, synchro-
nized with cell fate observations, would shed light on can-
cer drug effects at systems level. However, even if sufficient
data are available, it is challenging to construct a model of
cell signalling to explain the data and make accurate pre-
dictions. As more “omics” data about cancer are available
recently, computational methods for modelling and discov-
ery of cancer cell fate are becoming more important.
Cancer cell fate in response to drugs has been studied
with both discrete and continuous models using knowledge
driven approaches. For example, the study in [2] focused
on discrete modelling of the apoptosis network, by con-
structing a model for cell fate with 25 key regulatory genes
(e.g. Casp3, BCL2, XIAP, etc.). Cell survival pathways with
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cell death (necrosis and apoptosis) pathway were combined
to model three cell fates, namely apoptosis, proliferation
and survival. GINsim [3] software was used to perform
simulation to assess the importance of Cytokines (e.g. TNF,
FASL) in deciding the cell fate. In another study, Hong
et al. [4] analysed the continuous model of apoptosis trig-
gered by the drug Cisplatin. They initially constructed
apoptosis pathways using existing literature. This model
was configured to respond to the external stimulus, i.e. the
drug Cisplatin. To analyse the functions of various signal-
ling pathways and their crosstalk, Hong et al. integrated
three apoptosis pathways, namely death receptors (e.g.
FasL) induced pathway, mitochondrial pathway and ER
stress pathway. Using their differential equation based
model they found that the apoptosis caused by Cisplatin
was dependent on doses and time. The level of apoptosis
was almost stagnant at higher concentration of drug. They
also observed that mitochondrial pathway has strongest
effect on apoptosis (among the three pathways) [4].
On the other hand, data driven modelling of signalling
pathways is a promising approach to uncover regulatory
mechanism for cancer cell fate. The study in [5] investi-
gated three lines of breast tumour, namely BT-20,
MDA-MB-453 and MCF7, for their responses to various
combinations of exposure to several genotoxic drugs
and signalling inhibitors. The authors found that it was
the pre-treatment, rather than co-treatment or post-
treatment, of a subset of TNBCs with Epidermal Growth
Factor Receptor (EGFR) inhibitors that can enhance the
sensitivity of tumour cells in their apoptosis response to
DNA-damaging chemotherapy. The study suggested that
such a treatment may lead to the rewiring of oncogenic
signalling pathways which has the potential to make
cancer cells more susceptible to death. It was further
reported that the inhibition of EGFR in a time-staggered
way may be responsible for sensitising tumour cells to
genotoxic drugs. However, simultaneous co-administra-
tion of inhibitors and genotoxic drug could not make the
tumour cells less tumorigenic. To test these hypotheses,
the study systematically investigated a series of drug com-
binations for their effects on breast cancer cells. The study
suggests that rewiring inside the tumour cells is responsi-
ble for the increase of drug sensitivity, but it is not clear
where and how the rewiring happens. The rewiring
involves alterations of signalling pathways such as addition
or deletion of edges in the network, change in reactions
rates, and change in the concentration of molecules. Since
it is more challenging to directly observe rewiring signal-
ling pathways by wet lab experiments, computational
methods for predicting rewiring from data would be useful
for study of cancer drug effect and cell fate decisions.
In this paper, we propose a hybrid modelling approach
that combines the advantages of knowledge-driven and
data-driven approaches for modelling cancer signalling
pathways and cell fate decisions. From a generic apopto-
tic network, we simulate the time series data of signal-
ling proteins using ODEs based on a network candidate
modified from the generic network by in silico rewiring;
then the simulated data are compared with the real
data. This in in silico rewiring, simulation and data fit-
ting is repeated iteratively to improve the goodness of
fit using Genetic Algorithm. Through such an optimisa-
tion we can detect the topology alterations of the net-
work that allows close fitting of model to the real data.
As such, network rewiring can be inferred from real
data. Most of rewiring events predicted by our model
are supported by existing literature.
Methods
Our work is broadly organised in three interrelated parts.
We initially constructed a basic apoptosis network (say
N1) which is free of abnormal mutation and represents
signalling pathways inside a healthy cell. We used the
biological data for our studies based on the phosphoryla-
tion levels of signalling proteins and phenotypic
responses taken from the biological experiments con-
ducted in [5]. Hereafter, we call this data set as “Yaffe’s
data”. We compared the simulation data from this net-
work with the Yaffe’s data using Genetic Algorithm and
Dynamic Time Warping for DMSO treatment and
derived a tumorigenic network (say N2). Then we modi-
fied N2 to fit with Yaffe’s data to derive a drug sensitive
network (say N3). N1 was constructed directly from litera-
ture; N2 consisted of edges added and deleted from N1 by
Genetic Algorithm; N3 consisted of edges added and
deleted from N2 by Genetic Algorithm.
Data
The Yaffe’s data set contains six types of cellular pheno-
typic responses from three cancer cell lines, namely triple
negative BT-20, Hormone sensitive MCF-7 and HER2
overexpressing MDA-MB-453. The six phenotypes are
Apoptosis, Proliferation, G1, S, G2 and M. These pheno-
typic responses are linked with on 35 signalling proteins
(only 32 available in the published data set). The signal-
ling molecule data available contains 8 time points (0, 1,
2, 3, 4, 5, 6 and 7). The phenotypic responses were mea-
sured at five time points (0, 6, 7, 8 and 9), over 24 hours
in the panel of breast cancer cell lines. The cell fates and
signalling data are available for all the three cell lines.
The measurements of the signalling and cell fate data
have been done for six treatments namely DMSO, TAR,
DOX, DT, T-D and D-T. The apoptosis level is report-
edly high for the T-D treatment, meaning the cells are
now less tumorigenic for this treatment and thereby
more susceptible to death induced by DNA damage
response pathways. The study in [5] employs several
mathematical modelling approaches to relate signalling
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data to cell phenotypes. Principal component analysis
(PCA) was used to identify co-variation between signals,
whereas partial least-squares regression (PLSR) was used
to identify co-variation between molecular signals and
corresponding cellular phenotypic responses. In both
PCA and PLSR modelling, the input vectors contained
quantitative measurements of the signalling proteins.
Apoptosis network construction
We constructed a generic apoptosis network consisting
of 22 signalling proteins including 18 proteins from the
biological experiment conducted in [5]. The authors of
[5] provided Variable Importance in Projection (VIP)
scores for different selected proteins to demonstrate how
the selected proteins were useful for predicting apoptosis
of different cell lines. For example, proteins with VIP
score > 1 were important variables, proteins with VIP
score < 0.5 were unimportant variables. Since our goal is
to test the goodness of fit of our model with Yaffe’s data,
we selected proteins that have been measured in the
experiment. Also, our signalling network includes mole-
cules based on the prior knowledge from several path-
ways playing critical roles in inducing cell death, which
include DNA damage response and cell death pathways,
stress response pathways, etc.
The network diagram is shown in Figure 1. We con-
structed connections between various signalling proteins
in our basic apoptosis network using the existing litera-
ture. HER2 is a cell transmembrane receptor which plays
a significant role in breast cancer by suppression of
tumour growth. It provides growth signals in PI3KAKT
and Ras-MAPK pathways. HER2 also suppresses p53-
mediated apoptosis by upregulation of MDM2 by activa-
tion of AKT. p53 also participates in promoting apoptosis
by sensing DNA damage and can upregulate pro-apopto-
tic Bcl-2 proteins (e.g. PUMA) as well as suppress IAPs
(e.g. survivin) [6]. PUMA is a pro-apoptotic protein and
plays crucial roles in apoptosis. Tumour suppressor gene
p53 regulates the expression of PUMA. Once activated,
PUMA frees the apoptosis regulator Bax and Bak owing
to its high affinity with Bcl-2 oncogenic group of pro-
teins. The freed proteins further transduce the apoptotic
signals to the mitochondria. This causes the Caspases to
be activated and the activated caspases eventually lead to
the cell death [7]. Activation of pro-apoptotic BAX/Bak
facilitates heme protein cytochrome c being released
from the inner mitochondria membrane [8,9]. The cyto-
chrome c further stimulates Casp9, which then stimulates
Casp3 and Casp7, which eventually lead to apoptotic cell
death [10]. Up-regulation of DAPK induces apoptosis by
enhancing response of tumour suppressor p53 whereas
down-regulation of DAPK reduces the response of p53 to
several oncogenes including c-Myc and E2F-1. The acti-
vated form of DAPK further activates the Beclin-1 by
phosphorylation. Beclin-1 activation is crucial for Autop-
hagy and also for its crosstalk with apoptosis.
Beclin-1 is an autophagy protein that interacts with Bcl-
2, an anti-apoptotic protein, and they form a complex, to
facilitate a switch from autophagy to apoptosis and vice-
versa. The activity of Beclin-1, owing to the complex for-
mation of Bcl-2:Beclin-1 complex, is suppressed by Bcl-2
protein [11,12]. STAT3 is an important gene due to its
roles in regulating cell fate including cell survival and cell
growth. Experimental results have shown that a decreased
level of STAT3 leads to a reduced level of Bcl-2 [13]. Acti-
vation of STAT3 gene stimulates transcription of quite a
few cell fate controlling genes, which include some of the
members of Bcl-2 protein family [14]. The proteins Wee1
and Cdk1 (Cyclin-dependent kinase 1) play very important
roles in regulating cell cycle. During mitosis, the size of a
cell is controlled by the inhibition of Cdk1 by Wee1 which
prevents the cell from going into mitosis. The suppression
of Cdk1 by Wee1 is done by phosphorylation of Cdk1
[15]. Cdk1 in turn phosphorylates Bcl-2 and suppresses its
activity [16]. The EGF receptor (EGFR) is a cell membrane
protein receptor with high affinity for several specific pro-
teins (ligands) including Epidermal Growth Factor (EGF).
EGFR further activates many targets including Jun N-
terminal kinases (JNKs). Mutation in EGFR may lead to its
uncontrolled expression which can potentially cause
uncontrolled cell growth, which is a hall mark of cancer
[17]. The Bcl-2-associated death promoter (BAD), another
member protein from Bcl-2 group of proteins, is highly
pro-apoptotic. JNK can inhibit apoptosis by phosphorylat-
ing BAD protein [18]. Trimeric Tumor Necrosis Factor
(TNF) activates multiple signalling pathways which in turn
lead to apoptosis. TNF interacts with death domain (DD)
protein TRADD. TRADD in turn has been shown to have
high affinity for RIP [19]. Casp3 mediates cleavage of mul-
tiple proteins and causes DNA fragmentation which even-
tually leads to apoptosis [2].
Simulation with ODE
Using the topology of the basic apoptosis network (Figure 1),
constructed from the literature, we derived a computational
model by generating rate equations for the network. The
complete set of differential equations for the basic network
N1 is given in Table 2. Concentration of each molecule is
represented by enclosing the molecule name with square
brackets (e.g. [Casp8]). Reaction rate constants are repre-
sented as rc1, rc2 etc. For example, based on the basic net-
work N1 in Figure 1, the differential equations for the
change of concentration of AKT and p53 were derived as:
d
dt
AKT = − [AKT] · rc18 + [HER2] · rc20,
d
dt
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Figure 1 Basic apoptosis network and various rewiring events. Basic apoptotic network contained all edges except the broken edges (green
and blue). Edges represented by thick red colour were deleted by Genetic Algorithm while inferring N2 from N1. Broken edges represented by
green colour were inserted by Genetic Algorithm while inferring N2 from N1. Edges represented by magenta colour were deleted by Genetic
Algorithm while inferring N3 from N2. Broken edges represented by blue colour were inserted by Genetic Algorithm while inferring N3 from N2.
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Table 1 Genetic Algorithm for finding mutation in apoptotic network
INPUT: Objective function, Network Topology(NT) in the form of Adjacency vector of size n × n, reaction rate constants vector of size n × n,
maximum number of generations Max num gen for the algorithm, biological data measurements
OUTPUT: A vector consisting topology of best uncovered network, score vector S, for such uncovered networks
1. NT0 ⇐ topology
2. RC0 ⇐ rate constants
3. Max_num_itr ⇐ total number of iteration allowed
4. S0 ⇐ 0
5. Derive Population P (randomly generated networks)
6. For max_ num_gen times do:
7. Derive rate equations for each network in P
8. Solve each of the Rate equations
9. Derive numerical solutions (time series data)
10. Compare the simulation results with Yaffe’s data using DTW Objective function and calculate the Score
11. Select 50 best score
12. Perform crossover among best selected networks to formulate next generation, total of 100 networks again. The crossover points are selected
based on random numbers. The networks to be crossed over are selected randomly.
13. Perform mutation for each bit with the probability of 0.01, for each of the hundred networks.
14. Set new population P = mutated network from step 13
15. Check for the convergence.
16. If network not converged, go to step 5
7. Output solution set.
Table 2 Differential equations for the basic apoptosis network N1 (Figure 1)




























































BCL2 - [BCL2]·rc5 + [p53]·rc10 + [CDK1]·rc14 + [JNK]·rc15 +[BID]·rc16 +[STAT3]·rc22 - [BCL2]·rc26
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where rc18 is the binding rate constant from AKT to
p53 and [AKT] is the concentration of the AKT mole-
cule. Also, rc20 represents the binding rate constant for
HER2 to AKT. Similarly, for p53, variables in the corre-
sponding equation incorporate information for the mole-
cular concentrations and the binding rate constants for
AKT and p53.
In our study, the ODEs were solved using the standard
Matlab library function ode45. This function can interpret
the differential equations in the form of rate reactions.
The ode45 accepts the initial values of the molecules and
the time duration in the form of function parameters
[20,21]. Using this procedure, we derived the rate equa-
tions and time course data for all twenty-two signalling
proteins. The initial concentrations of the signalling mole-
cules were set to dimensionless numeric value of one [22].
Some of the rate constants were taken directly from the
literature. These include Casp9 & Casp3, Casp9 & XIAP,
Casp8 & BID, Casp3 & XIAP, Casp3 &Casp8, Casp3 &
Apop, p53 & PUMA, Casp3 & Casp6 and XIAP & SMAC
[4,23,24]. The remaining parameters were generated ran-
domly but we verified them by Partial Least Square
Regression (PLSR) test. We also performed sensitivity ana-
lysis of the model parameters by varying the model para-
meters to ensure overall robustness of the model to the
small variations of parameters (see result section for PLSR
test and sensitivity analysis).
Genetic algorithm
We applied the Genetic Algorithm to search for the net-
work topologies that fit the real data well, in order to
uncover the rewiring inside the tumour cells. There are
several optimisation techniques available in the literature
which can be used to search for the network topologies.
These techniques include, for example, Simulated Anneal-
ing, Evolution Strategies, Genetic Algorithm, Evolutionary
Programming etc. Simulated Annealing has population
size of only one which represents current solution, thus
the solution space is not as wide as GA. Similarly, Evolu-
tionary Programming can only use mutation operator. By
contrast, Genetic Algorithms have several solutions in the
beginning and crossovers can be performed to generate
the diversity in the population of network structures.
While the probabilistic selection of GA helps us simulate
the stochastic biochemical networks in better ways, Evolu-
tion Strategies uses deterministic selection [25,26]. After
comparing these techniques, we decided to use Genetic
Algorithm in our study. As a global search technique, GA
is considered to be very robust as it makes very few
assumptions about the problem under consideration [27].
The implementation of Genetic Algorithm assumes
that the variables from problem can be represented in
the form of binary strings typically known as Chromo-
somes. A feasible solution is also encoded in the form
of a chromosome. The initial population for the Genetic
Algorithm is a random set of chromosomes. These
chromosomes are evaluated using an objective function.
The chromosomes representing better solutions are
given higher probability to reproduce offspring in next
generation. Chromosomes with lower scores are
removed from the solution set. The pseudocode for the
Genetic algorithm used in our experiments is given in
Table 1.
The network topology is represented by an adjacency
matrix. For each edge between two nodes in the network
there is a Boolean value of ‘ 1’ in the matrix, and a ‘ 0’
entry represents the absence of connection between the
corresponding nodes. The adjacency matrix can be modi-
fied in Genetic Algorithm as follows [27]. We initially
derive the chromosome (vector of 1 × 484) by concatenat-
ing the rows of the adjacency matrix of the network into
one binary string. As such, the network topology of 22
nodes is represented as a chromosome i.e. a binary string
of length 484. The topology of the basic network N1 was
changed randomly using mutation and crossover. The
crossover points were randomly selected uniformly from




























MOMP +[DAPK1]·rc28 - [MOMP]·rc29 - [MOMP]·rc30
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the range of [1:484]. Generally, the mutation rate for any
particular bit is less than 1% [27]. In our implementation
the mutation operator was applied to each of the bit in a
chromosome (after performing crossover) with a low
probability value of 0.01. Once the process of selection of
chromosome, recombination and mutation is finished, the
population of next generation is evaluated [27].
To compare the time series data, we used Dynamic
Time Warping (DTW) [28,29]. DTW is widely used for
comparing time series data, due to its strength to capture
the variation in data that may vary owing to different
speed. Hence, DTW can calculate the optimal match
between two temporal data. The objective function of












D[i, j − 1]
D
[
i− 1, j− 1] ,
where cost = dist(s[i], t[j]), D is a matrix of size [0..n,
0..m], D[0, 0] = 0. Initially each entry of D[i, 0], for 0 <i
≤ n, and D[0, j], for 0 <j ≤ m, are set to infinity, i.e. a
larger value which cannot be part of the data sequences.
Here s[1..n] and t[1..m] are the two time series repre-
senting protein phosphorylation levels over time points
to be compared, whereas s[i] and t[j] represents the data
at time points i and j respectively. For any two numbers
s[i] and t[j], dist(s[i], t[j]) represents the distance
between the numbers, e.g. dist(s[i], t[j]) = |s[i] −t[j]|.
The objective function aims to measure the goodness of
fit between the simulation data and real data.
Results
PLSR for simulation data from N1
We first used Partial Least Squares Regression (PLSR) to
test if the simulation data generated using our basic net-
work N1 were reliable for performing the prediction of
network rewiring. PLSR is used for mapping independent
variable with dependent variables (e.g. mapping signalling
molecules to phenotypic responses) [30]. In a PLSR plot,
if a predictor variable is closely associated with the pre-
dicted variable, then such a predictor variable influences
the predicted variable relatively more strongly than the
predictor variable who is far away in the PLSR plot. For
reaction parameters, we ensured that the selected para-
meter values enabled us to associate the important pre-
dictor variables like Caspases, XIAP, SMAC etc. closely
with the apoptosis. The Partial least Square Regression
(PLSR) plot for the simulation data from the basic net-
work from N1, is given in Figure 2, which PLSR plot
shows the close association between apoptosis and sev-
eral apoptotic proteins. This result is consistent with the
results reported by Lee et al. [5].
Figure 2 PLSR plot for simulation data for apoptosis from network N1.
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Inferring the tumorigenic network N2
From network N1, we will infer the rewired network N2
corresponding to cancer cell lines by fitting simulated
data to the cancer specific dataset. To this end, we
adopt Genetic Algorithm for multiple generations to
search for the most likely network rewiring events and
collected 50 rewired networks in each generations along
with corresponding scores. The Genetic Algorithm per-
formed rewiring on the basic apoptotic network of
Figure 1. The comparison for simulated data from net-
work N1 and Yaffe’s data for control treatments using
Genetic Algorithm, before and after rewiring event in
network N1, is shown in Figure 3 and 4.
Due to inherent randomness in Genetic Algorithm,
the edges added and deleted in N1 (while inferring N2)
were different among different run of simulations. Some
of the changes in the network were found to be more
frequent compared to other. So, just few runs of simula-
tion couldn’t be relied upon to find the changes in the
N1 network causing cancer. Therefore, to find consistent
(or conserved re-wirings) changes to the network, we
performed the simulation for 150 times for inferring N2
from N1 and another 150 rounds of simulation for infer-
ring N3 from N2. The changes which occurred in the
network with the highest frequency were selected
to construct N2 (and subsequently N3). The most
frequently removed edges in the N1 network while
inferring N2 were SMAC-XIAP, Casp8-Casp3 and p53-
PUMA. For 150 rounds of simulations, each of these
deletions occurred with a frequency of 146, 143 and 141
respectively. The network edges found to be inserted in
the N1 by the Genetic Algorithm with the highest fre-
quencies were XIAP-Casp8 and TNFR-Stat3, with fre-
quencies of 149 and 146.
We verified the various rewiring events using the exist-
ing literature and confirmed the validity for the above
mentioned network changes. p53 is a tumour suppressor
and controls the regulation of PUMA. PUMA induces
apoptotic signals inside the cells. Less activity of PUMA
leads to apoptosis deficiency which in turn leads to the
increased risk of cancer [31]. We also realised that
SMAC down-regulates XIAP and XIAP down-regulates
Casp3, a pro-apoptotic protein. So if SMAC is working
properly, there will be more cell death leading to less
tumorigenic behaviour by cells. But if SMAC is not able
to down-regulates XIAP, there will be less apoptosis and
so more chances of cancer [2]. We also came across lit-
erature evidence highlighting the critical role of Casp8
for affecting breast cancer directly [5,32]. STAT3 inter-
acts with various molecules involved in programmed cell
death, regulating their functions including MOMP for-
mation, which leads to the release of the cytochrome c
[33]. XIAP inhibits the processing of Casp8. In fact, pro-
teolytic processing of several caspases, including Casp9,
Figure 3 Simulation results for Genetic Algorithm: fitting experimental data with simulation data. (A) Simulation result for basic
apoptotic network, (B) Simulation result for DMSO treatment. (C) Comparing N2 based simulation data with ERL-DOX treatments data by
correlation of apoptosis rates over time points. (D) Simulation result for ERL-DOX treatments.
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is not allowed in the presences of XIAP. The lack of pro-
cessing of Casp8 and Casp9 allows them to interact with
Casp3 and promote apoptosis [34]. TNFR activates the
Stat3 signalling. The stimulation of TNFR leads the phos-
phorylation of the Stat3 and Stat5b and the phosphory-
lated molecules are trans-located into the nucleus [35].
Inferring the drug sensitive network N3
After inferring N2 from N1, our aim was to infer the drug
sensitive network (N3), by fitting modified topology of N2 to
the real data of drug treatment. Before predicting rewiring
of N2, we plotted the N2 based simulation data with the real
dataset of signalling and cell fate of cancer cells after treat-
ment with drugs. The plot is shown in Figure 5. We again
used Genetic Algorithm to search for the network rewirings
that allow better fitting of simulation to the real data. For
each run of simulation, we compared the simulation data
with the drug sensitive experimental apoptosis data for
ERL-DOX treatments. The best network plot, uncovered
using Genetic Algorithm, is shown in Figure 6. The edges
of N2 that were most frequently removed were BIM-Casp9
and EGFR-Casp8, deleted 141 and 137 times respectively.
The network edges inserted with highest frequencies by the
Genetic Algorithm were Casp8-RIP and Casp8-MOMP,
inserted 144 and 135 times respectively. These rewiring
events have been mentioned in related literature [2,5,17,36].
Sensitivity analysis of the model
To analyse the behaviour of our model with respect to
the fluctuations in model parameters, we verified our
model by performing sensitivity analysis for the rate
constants. We initially tested apoptosis level for each of
the molecules by reducing the parameter by 30%. Then
we increased the parameter by 30%. Among all the para-
meters, “Casp3-Casp8” and “Casp3-Apop”, were found
to be very sensitive, affecting the apoptosis level to the
maximum. We found that the level of apoptosis for
most of the parameters changed only slightly, within
+/-5%, except for the most sensitive parameters, “Casp3-
Casp8” and “Casp3-Apop”, which affected the level of
apoptosis by +/-20%.
To test the robustness of our model, we also per-
formed the perturbation test. We changed the initial
concentration of each of the molecules and identified
the most sensitive parameters of the model. The apopto-
sis level was predicted for each of the molecule whose
initial concentration was reduced by 30%. Then, for
each molecule we increased the initial concentration by
30%. We found that the level of apoptosis for most of
the initial concentrations was stable, except for the con-
centration of the molecules with parameters of “Casp3-
Casp8” and “Casp3-Apop”. This suggests an overall
robustness of our model.
Discussion and conclusion
In our proposed study, we used Genetic Algorithm to
infer rewiring of the apoptotic network. The most fre-
quent rewiring events are selected, and most of them
were found to be consistent with existing literature.
However, using Genetic Algorithm we may not find a
Figure 4
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globally optimal solution, as some of the network rewir-
ing events might have been missed by the Genetic Algo-
rithm based searching. So far we have included only 18
out of 32 proteins in the Yaffe’s data. A network with
more signalling data may help us understand the path-
way changes in more comprehensive ways. In future,
with expanded apoptosis network and more proteins, we
would be able to detect more network alterations
Figure 5
Figure 6
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through comparisons between simulation data and
experimental data. Also, beside Genetic Algorithm we
plan to use other computational techniques (e.g. Simu-
lated Annealing). In this paper Yaffes data set has been
used. Our next goal is to construct a larger network
model for cancer cell phenotypic responses which can
simulate observations for some other datasets taken
from multiple sources.
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